138 related articles for article (PubMed ID: 20186930)
1. Dipeptidyl peptidase expression during experimental colitis in mice.
Yazbeck R; Sulda ML; Howarth GS; Bleich A; Raber K; von Hörsten S; Holst JJ; Abbott CA
Inflamm Bowel Dis; 2010 Aug; 16(8):1340-51. PubMed ID: 20186930
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and histological changes in the small intestine of mice with dextran sulfate sodium colitis.
Yazbeck R; Howarth GS; Butler RN; Geier MS; Abbott CA
J Cell Physiol; 2011 Dec; 226(12):3219-24. PubMed ID: 21351101
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice.
Yazbeck R; Howarth GS; Geier MS; Demuth HU; Abbott CA
Front Biosci; 2008 May; 13():6850-8. PubMed ID: 18508699
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis.
Mimura S; Ando T; Ishiguro K; Maeda O; Watanabe O; Ujihara M; Hirayama Y; Morise K; Maeda K; Matsushita M; Funasaka K; Nakamura M; Miyahara R; Ozaki N; Goto H
Scand J Gastroenterol; 2013 Oct; 48(10):1152-9. PubMed ID: 24047394
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl peptidase 4 inhibitor sitagliptin protected against dextran sulfate sodium-induced experimental colitis by potentiating the action of GLP-2.
Ning MM; Yang WJ; Guan WB; Gu YP; Feng Y; Leng Y
Acta Pharmacol Sin; 2020 Nov; 41(11):1446-1456. PubMed ID: 32398684
[TBL] [Abstract][Full Text] [Related]
6. Development and resolution of experimental colitis in mice with targeted deletion of dipeptidyl peptidase IV.
Geier MS; Tenikoff D; Yazbeck R; McCaughan GW; Abbott CA; Howarth GS
J Cell Physiol; 2005 Aug; 204(2):687-92. PubMed ID: 15754331
[TBL] [Abstract][Full Text] [Related]
7. New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical Administration.
Salaga M; Mokrowiecka A; Zielinska M; Malecka-Panas E; Kordek R; Kamysz E; Fichna J
J Pharmacol Exp Ther; 2017 Oct; 363(1):92-103. PubMed ID: 28724693
[TBL] [Abstract][Full Text] [Related]
8. The effects of a TGR5 agonist and a dipeptidyl peptidase IV inhibitor on dextran sulfate sodium-induced colitis in mice.
Sakanaka T; Inoue T; Yorifuji N; Iguchi M; Fujiwara K; Narabayashi K; Kakimoto K; Nouda S; Okada T; Kuramoto T; Ishida K; Abe Y; Takeuchi T; Umegaki E; Akiba Y; Kaunitz JD; Higuchi K
J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1(Suppl 1):60-5. PubMed ID: 25827806
[TBL] [Abstract][Full Text] [Related]
9. Influence of CD26/dipeptidyl peptidase IV deficiency on immunophenotypic changes during colitis development and resolution.
Detel D; Buljevic S; Pucar LB; Kucic N; Pugel EP; Varljen J
J Physiol Biochem; 2016 Sep; 72(3):405-19. PubMed ID: 27125676
[TBL] [Abstract][Full Text] [Related]
10. Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
Reinhold D; Goihl A; Wrenger S; Reinhold A; Kühlmann UC; Faust J; Neubert K; Thielitz A; Brocke S; Täger M; Ansorge S; Bank U
Clin Chem Lab Med; 2009; 47(3):268-74. PubMed ID: 19676138
[TBL] [Abstract][Full Text] [Related]
11. The role of the complement and contact systems in the dextran sulfate sodium-induced colitis model: the effect of C1 inhibitor in inflammatory bowel disease.
Lu F; Fernandes SM; Davis AE
Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G878-83. PubMed ID: 20338925
[TBL] [Abstract][Full Text] [Related]
12. Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.
Bank U; Heimburg A; Helmuth M; Stefin S; Lendeckel U; Reinhold D; Faust J; Fuchs P; Sens B; Neubert K; Täger M; Ansorge S
Int Immunopharmacol; 2006 Dec; 6(13-14):1925-34. PubMed ID: 17161345
[TBL] [Abstract][Full Text] [Related]
13. The effect of CD26-deficiency on dipeptidyl peptidase 8 and 9 expression profiles in a mouse model of Crohn's disease.
Buljevic S; Detel D; Pugel EP; Varljen J
J Cell Biochem; 2018 Aug; 119(8):6743-6755. PubMed ID: 29693275
[TBL] [Abstract][Full Text] [Related]
14. Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice.
Horino J; Fujimoto M; Terabe F; Serada S; Takahashi T; Soma Y; Tanaka K; Chinen T; Yoshimura A; Nomura S; Kawase I; Hayashi N; Kishimoto T; Naka T
Int Immunol; 2008 Jun; 20(6):753-62. PubMed ID: 18381351
[TBL] [Abstract][Full Text] [Related]
15. Novel peptide inhibitor of dipeptidyl peptidase IV (Tyr-Pro-D-Ala-NH
Salaga M; Binienda A; Draczkowski P; Kosson P; Kordek R; Jozwiak K; Fichna J
Peptides; 2018 Oct; 108():34-45. PubMed ID: 30179653
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis.
Nighot P; Al-Sadi R; Rawat M; Guo S; Watterson DM; Ma T
Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G988-97. PubMed ID: 26514773
[TBL] [Abstract][Full Text] [Related]
17. Purified PEGylated porcine glucagon-like peptide-2 reduces the severity of colonic injury in a murine model of experimental colitis.
Qi KK; Wu J; Wan J; Men XM; Xu ZW
Peptides; 2014 Feb; 52():11-8. PubMed ID: 24274971
[TBL] [Abstract][Full Text] [Related]
18. G protein-coupled receptor 40 activation ameliorates dextran sulfate sodium-induced colitis in mice via the upregulation of glucagon-likepeptide-2.
Kato S; Utsumi D; Matsumoto K
J Pharmacol Sci; 2019 Jun; 140(2):144-152. PubMed ID: 31242961
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor receptor 1 tyrosine kinase signaling facilitates healing of DSS-induced colitis by accumulation of Tregs in ulcer area.
Betto T; Amano H; Ito Y; Eshima K; Yoshida T; Matsui Y; Yamane S; Inoue T; Otaka F; Kobayashi K; Koizumi W; Shibuya M; Majima M
Biomed Pharmacother; 2019 Mar; 111():131-141. PubMed ID: 30579252
[TBL] [Abstract][Full Text] [Related]
20. Role of TNF receptors, TNFR1 and TNFR2, in dextran sodium sulfate-induced colitis.
Stillie R; Stadnyk AW
Inflamm Bowel Dis; 2009 Oct; 15(10):1515-25. PubMed ID: 19479745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
